[Therapeutic experience with an ultra-long term sulfonamide (sulfamethoxypyrazine) in dermatitis herpetiformis Duhring].
D000368:Aged; D000814:Aniline Compounds / Q000008:administration & dosage*; D003874:Dermatitis Herpetiformis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008134:Long-Term Care; D008297:Male; D011719:Pyrazines / Q000008:administration & dosage; D013997:Time Factors
D000814:Aniline Compounds; D011719:Pyrazines
Therapieerfahrung mit einem Ultralongzeit-Sulfonamid (Sulfamethoxypyrazin) bei Dermatitis herpetiformis Duhring.